Use before modern control
Plants, preparations and medicines entered societies through very different cultural and clinical routes.
Social history
Drug history
Drugs have histories before they have headlines. Follow substances through medicine, trade, culture, prohibition, treatment and harm reduction — then connect those histories to today's risks.
TD ConsultancyPublished 5 August 2026Reviewed 5 August 2026Legislation · archival sources · TD professional guides
A changing social system
Four recurring turning points
Trade changes scale
Extraction, synthesis, colonial commerce and pharmaceutical production altered availability and meaning.
Control & moral narratives
International conventions and national laws grew alongside media narratives that did not affect all groups equally.
Treatment & harm reduction
Needle programmes, naloxone, evidence-based treatment and drug checking challenged purely punitive responses.
Individual histories
Follow one substance through time
Each history page marks established evidence, cautions where stories are contested, and links back to present-day drug information.
A history of alcohol
Fermentation, commerce, licensing, medicine and the changing place of alcohol in British life.
Read the history →A history of cocaine
From coca traditions to medical cocaine, global commodity markets, prohibition and contemporary supply.
Read the history →A history of crack cocaine
How a smokeable cocaine market acquired a distinct name, price structure and powerful political narrative.
Read the history →A history of cannabis
Fibre, medicine, culture, prohibition and the modern distinction between illicit cannabis and prescribed cannabis-based medicines.
Read the history →A history of opium and heroin
Medicine, empire, trade, pharmaceutical development and the long history of opioid control.
Read the history →A history of heroin
Diamorphine's path from pharmaceutical product to a controlled medicine and illicit opioid market.
Read the history →A short history of opioids
From plant-derived opiates to medicines, heroin and highly potent synthetic opioids.
Read the history →A history of amphetamine
Pharmaceutical stimulant, wartime and post-war use, prescribing controls and illicit markets.
Read the history →A history of methamphetamine
A potent stimulant shaped by pharmaceutical manufacture, conflict, changing markets and recurring media panic.
Read the history →A history of MDMA
An early pharmaceutical compound, later therapeutic interest, dance culture and Class A control.
Read the history →A history of ketamine
Anaesthetic medicine, veterinary and emergency use, club markets and new clinical research.
Read the history →A history of benzodiazepines
From safer-seeming sedatives to dependence awareness, prescribing caution and illicit tablets.
Read the history →A history of psychedelics
Traditional uses, twentieth-century research, prohibition, counterculture and renewed clinical study.
Read the history →A history of nitrous oxide
Anaesthesia, entertainment, food propellant and the changing legal response to non-medical use.
Read the history →A history of synthetic cannabinoids
Research chemicals, rapidly changing retail products, prohibition and a persistent mismatch between branding and pharmacology.
Read the history →A history of Lean and codeine-based drinks
Prescription cough syrups, US regional music culture, commercial imagery and global imitation.
Read the history →A history of nitazenes
Mid-twentieth-century benzimidazole opioid research compounds re-emerging in twenty-first-century illicit markets.
Read the history →History is also policy history
Drug controls have been shaped by evidence, politics, trade, colonial relationships, media narratives and social inequality. Describing that history does not require romanticising drug use or pretending every policy decision had the same intent or effect.
What continues into the present?
Criminalisation, stigma, treatment institutions, pharmaceutical markets and harm-reduction movements all leave institutional traces. Understanding them can explain why present-day harms are not produced by pharmacology alone.
History into practice
Lean (Purple Drank): A Practitioner’s Guide
Explore the mixture’s medical roots, cultural history and present-day opioid and depressant risks in greater professional depth.
Buy on Amazon ↗